To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06205290
Title A Study to Compare the Efficacy and Safety of Lisocabtagene Maraleucel vs Investigator's Choice Options in Adult Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, Whose Disease Has Failed Treatment With Both BTKi and BCL2i Therapies
Recruitment Withdrawn
Gender both
Phase Phase III
Variant Requirements No
Sponsors Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | SWE | NOR | NLD | ITA | GBR | FRA | ESP | DEU | BEL | AUT


No variant requirements are available.